Literature DB >> 14692364

Managing bowel obstruction in ovarian cancer using a percutaneous endoscopic gastrostomy (PEG) tube.

Lynne Jolicoeur1, Wylam Faught.   

Abstract

An estimated 2,500 women were diagnosed with and 1,500 died from ovarian cancer in Canada in 2002. Up to 42% of patients in the palliative phase develop a malignant bowel obstruction. Options for management include medical therapy, surgery, and/or a percutaneous endoscopic gastrostomy (PEG) tube. The objective of this quality improvement study was to: 1) examine if successful palliation was achieved using a PEG tube, and 2) identify opportunities to improve the quality of nursing care provided. A retrospective review of 24 patient records revealed that 75% did not have nausea/vomiting by time of discharge; 92% resumed a clear fluid diet; 83% were discharged from the acute care setting; and 70% did not require re-admission. A PEG tube may effectively palliate women with non-operable bowel obstruction in advanced/recurrent cancer of the ovary. Opportunities for improving care are presented.

Entities:  

Mesh:

Year:  2003        PMID: 14692364     DOI: 10.5737/1181912x134212215

Source DB:  PubMed          Journal:  Can Oncol Nurs J        ISSN: 1181-912X


  4 in total

1.  Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction.

Authors:  Anne Dittrich; Barbara Schubert; Michael Kramer; Felicitas Lenz; Karin Kast; Ulrich Schuler; Markus K Schuler
Journal:  Support Care Cancer       Date:  2017-04-22       Impact factor: 3.603

2.  Non-Surgical Management of Malignant Bowel Obstruction in Advanced Ovarian Cancer patients: A Systematic Review and Meta-Analysis.

Authors:  Praveena Idaikkadar; Athina Georgiou; Simon Skene; Agnieszka Michael
Journal:  Am J Hosp Palliat Care       Date:  2021-09-07       Impact factor: 2.090

3.  Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer.

Authors:  Robert D Morgan; Sofia Stamatopoulou; Nerissa Mescallado; Geoff Saunders; Richard Welch; Claire Mitchell; Jurjees Hasan; Andrew R Clamp; Gordon C Jayson
Journal:  ESMO Open       Date:  2019-03-21

4.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.